Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show
Spring on the Road
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Oragenics Inc
(NY:
OGEN
)
0.2740
+0.0034 (+1.26%)
Official Closing Price
Updated: 8:00 PM EST, Nov 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Oragenics Inc
< Previous
1
2
3
4
5
6
Next >
Why Nextracker Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
February 01, 2024
Shares of Nextracker Inc. (NASDAQ: NXT) rose sharply during today’s pre-market trading after the company reported better-than-expected thi
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
January 31, 2024
Via
Benzinga
Oragenics Announces Termination of At-The-Market Offering Program
January 23, 2024
From
Oragenics, Inc.
Via
Business Wire
Oragenics Completes Acquisition of Odyssey Health’s Neurological Assets
January 02, 2024
From
Oragenics, Inc.
Via
Business Wire
Oragenics's Return On Capital Employed Insights
December 27, 2022
Via
Benzinga
Oragenics Issues Update to Shareholders
November 02, 2023
From
Oragenics
Via
Business Wire
Oragenics Announces Appointment of Bruce Cassidy and John Gandolfo to Board of Directors
October 18, 2023
From
Oragenics, Inc.
Via
Business Wire
Oragenics to Acquire Odyssey Health’s Neurological Drug Technology Pipeline Including Concussion Drug Candidate
October 05, 2023
From
Oragenics, Inc.
Via
Business Wire
Why AERWINS Technologies Shares Are Trading Higher By Around 90%; Here Are 20 Stocks Moving Premarket
October 02, 2023
Gainers AERWINS Technologies Inc. (NASDAQ: AWIN) shares rose 90.2% to $0.2297 in pre-market trading. Aerwins Technologies is considering strategic alternatives for non-core operations including, not...
Via
Benzinga
Why Accolade Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
October 05, 2023
Gainers Orchard Therapeutics plc (NASDAQ: ORTX) shares climbed 97.7% to $15.98 after the company agreed to be acquired by Japan's Kyowa Kirin for $16.00 per ADS in cash plus an additional contingent...
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
September 29, 2023
Via
Benzinga
Oragenics Enters into Agreement with Lantern Bioworks for Replacement-Therapy Assets
September 29, 2023
From
Oragenics, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's After-Market Session
September 20, 2023
Via
Benzinga
Oragenics, Inc. Announces Private Placement
August 07, 2023
From
Oragenics, Inc.
Via
Business Wire
Oragenics Project to Develop a Variant-Agnostic Protein Antigen for Use in its COVID-19 Intranasal Vaccine Receives Funding from CQDM
June 05, 2023
From
Oragenics, Inc.
Via
Business Wire
Oragenics to Participate in the World Vaccine Congress Washington
March 29, 2023
From
Oragenics, Inc.
Via
Business Wire
Stocks That Hit 52-Week Lows On Monday
March 27, 2023
On Monday, 89 stocks made new 52-week lows.
Via
Benzinga
Oragenics Announces Positive Results in Several Lantibiotics Compounds Against MRSA and VRE
March 14, 2023
From
Oragenics, Inc.
Via
Business Wire
Oragenics Appoints Janet Huffman as Chief Financial Officer Strengthening Executive Leadership Team
March 08, 2023
From
Oragenics, Inc.
Via
Business Wire
Oragenics Looks To Boost Potency Of Its Nasal COVID-19 Vaccine With New Licensing Pact
March 01, 2023
Via
Benzinga
Oragenics Enters into an Exclusive Global License Agreement with Inspirevax to Develop Intranasal Covid Vaccine Candidate
March 01, 2023
From
Oragenics, Inc.
Via
Business Wire
Oragenics, Inc. Regains Compliance with NYSE American
February 03, 2023
From
Oragenics, Inc.
Via
Business Wire
7 Short-Squeeze Stocks to Buy Before They Soar
January 30, 2023
If you’re hunting for bears, you’re going to need the right equipment. Targeting these compelling short-squeeze stocks to buy might help.
Via
InvestorPlace
Catalyst Pharmaceuticals, Xylem And Other Big Stocks Moving Lower On Monday
January 23, 2023
U.S. stocks traded higher, with the Dow Jones gaining over 300 points on Monday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Metacrine, Equillium And 3 Stocks To Watch Heading Into Tuesday
December 27, 2022
With US stock futures trading higher this morning on Monday, some of the stocks that may grab investor focus today are as follows:
Via
Benzinga
Oragenics, Inc. Discloses One-for-Sixty Reverse Stock Split
December 23, 2022
From
Oragenics, Inc.
Via
Business Wire
Oragenics Highlights Encouraging Toxicology Data From Intranasal COVID Vaccine Candidate
December 22, 2022
Via
Benzinga
Why AMC Entertainment Shares Are Trading Lower By Around 13%? Here Are 59 Stocks Moving In Thursday's Mid-Day Session
December 22, 2022
Gainers Core Scientific, Inc. (NASDAQ: CORZ) shares jumped 188% to $0.1471. Core Scientific shares dipped 75% on Wednesday after the company filed for Chapter 11 bankruptcy.
Via
Benzinga
Oragenics Reports Favorable Toxicology Results for its COVID-19 Intranasal Vaccine Candidate
December 22, 2022
From
Oragenics, Inc.
Via
Business Wire
Oragenics, Inc. Receives NYSE American Notice
December 20, 2022
From
Oragenics, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.